Cerus Corporation
CERSHealthcareNASDAQMedical Devices · Last scanned Sep 7, 2026
Scan Results
Daily timeframeCerus Corporation operates as a biomedical products company. The company carries a $521.9M market cap, placing it firmly in the small-cap category. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety.
Market Cap
$521.9M
Beta
1.80
P/E (TTM)
—
P/E (Fwd)
-518.00
EPS (TTM)
$-0.03
EPS (Fwd)
$-0.01
ROE
-10.8%
ROA
-0.5%
Cash
$56.3M
Total Debt
$76.8M
Free CF
$875,250
52W Change
99.2%
Annual Financials
Cash vs Debt
Where CERS stands vs its 150-day and 200-day moving averages
As of the September 3, 2026 close, CERS finished 6.12% above its 150-day moving average ($2.45) and 10.17% above its 200-day moving average ($2.36). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is CERS overbought or oversold?
At the September 3, 2026 close, CERS's RSI(14) was 35.7, in neutral territory (between 30 and 70). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
The company holds $56.3M in cash, though total debt stands at $76.8M. This level of leverage is common in the industry but worth monitoring as interest rate conditions evolve. The company generates $875K in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing. ROE of -10.8% points to negative capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. Revenue has grown from $130.9M (2021) to $206.1M (2025), reflecting a 58% increase over the period.
With a beta above 1.5, CERS tends to amplify broader market moves — both up and down. This higher volatility means larger price swings are common. No single metric tells the full story. Reviewing CERS's risk profile alongside its fundamentals and technical indicators provides a more complete picture.